Preclinical Research Results of Doer Biologics' DR10627 Published in Diabetes, Metabolic Syndrome and Obesity

2024-04-16

Read more

Preclinical Research Results of Doer Biologics' DR10627 Published in Diabetes, Metabolic Syndrome and Obesity

2024-04-16

Read more

Doer Bio published pre-clinical research results of the trispecific antibody DR30318 in Cancer Immunology, Immunotherapy

2024-04-12

Read more

Doer Biologics’Trispecific Antibody DR30206 Preclinical Research Published in International Immunopharmacology

2024-02-22

Read more

Dr. Huang was invited to Biomedical Innovation R&D Forum 2020

2020-10-26

Read more

[An interview with Dr. Huang] Exclusive experience in the development of innovative multispecific fusion protein drugs

2020-06-29

Read more

Doer Biologics published paper of a long-acting GLP-1R / GCGR dual-agonist for the treatment of diabetes and obesity

2019-12-16

Read more

Doer Biologics Received tens of millions RMB in its first financing

2019-02-13

Read more